WallStreetZenWallStreetZen

NASDAQ: ROIV
Roivant Sciences Ltd Stock Ownership - Who owns Roivant Sciences?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Roivant Sciences Ltd insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Eric VenkerPresident Immunovant CEO2025-11-207,051$20.27
$142.92kSell
Richard PulikCFO2025-11-201,235$20.27
$25.03kSell
Keith S. ManchesterDirector2025-11-19150,000$20.20
$3.03MSell
Daniel Allen GoldDirector2025-11-19125,000$20.16
$2.52MSell
Daniel Allen GoldDirector2025-11-19175,000$20.24
$3.54MSell
Keith S. ManchesterDirector2025-11-19175,000$20.24
$3.54MSell
Keith S. ManchesterDirector2025-11-19125,000$20.16
$2.52MSell
Keith S. ManchesterDirector2025-11-19850,000$20.25
$17.21MSell
Qvt Financial LPInsider2025-11-19175,000$20.24
$3.54MSell
Qvt Financial LPInsider2025-11-19125,000$20.16
$2.52MSell

1 of 15

ROIV insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ROIV insiders and whales buy or sell their stock.

ROIV Shareholders

What type of owners hold Roivant Sciences Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Qvt Financial LP16.99%118,188,624$2.48BInsider
Daniel Allen Gold16.00%111,254,034$2.33BInsider
Dexcel Pharma Technologies Ltd14.79%102,849,443$2.16BInsider
Keith S. Manchester10.94%76,087,972$1.60BInsider
Svf Investments Uk Ltd10.50%73,031,667$1.53BInsider
Sumitomo Chemical Co Ltd10.24%71,251,083$1.49BInsider
Fmr LLC8.74%60,766,984$1.27BInstitution
Vivek Ramaswamy6.76%47,011,613$985.83MInsider
Morgan Stanley6.37%44,322,857$929.45MInstitution
Sb Investment Advisers Uk Ltd5.80%40,315,127$845.41MInstitution

1 of 3

ROIV vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ROIV42.42%57.58%Net SellingNet Selling
BBIO63.43%36.57%Net SellingNet Selling
RVMD90.67%9.33%Net SellingNet Selling
SMMT7.35%92.65%Net BuyingNet Buying
IONS97.00%3.00%Net SellingNet Selling
View Top Biotech Stocks

Roivant Sciences Stock Ownership FAQ

Who owns Roivant Sciences?

Roivant Sciences (NASDAQ: ROIV) is owned by 72.11% institutional shareholders, 97.87% Roivant Sciences insiders, and 0.00% retail investors. Qvt Financial LP is the largest individual Roivant Sciences shareholder, owning 118.19M shares representing 16.99% of the company. Qvt Financial LP's Roivant Sciences shares are currently valued at $2.48B.

If you're new to stock investing, here's how to buy Roivant Sciences stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.